企业QQ
官方微信
苏州蚂蚁淘生物科技有限公司是一家创新型高科技生物公司，以常规生物学实验外包与生物学试剂为基础，放眼于生命科学领域的前沿技术服务，公司技术骨干有着多年的生物学科研背景，毕业于国内外名牌大学，并且有着丰富的项目经验，了解国内外科研行情，我公司力求为每一个客户提专业、针对性的实验方案。我公司以技术服务为支点，和国内外多家生物试剂公司有着密切的业务往来.公司特色技术服务包括：抗体药物研发、噬菌体抗体库、蛋白表达与传化、抗体制备、高通量测序、组学研究、生物信息学分析与方法建立、基础分子生物学技术外包、化学中间体合成、原料药物研发、论文编写等。我公司秉承”诚信做人，认真做事，服务至上“，希望用我们的专业知识和项目经验为国内科研客户解决科研问题，祝您科研之路畅通无阻！
Enzo Life Sciences, Inc. is a recognized leader in labeling and detection technologies with over 40 years’ experience in providing for the research and diagnostics markets. Enzo develops a wide range of products including proteins, antibodies, peptides, small molecules, and labeling probe dyes. They also offer hundreds of ELISA immunoassay kits and enzyme activity assay kits in a variety of formats to service the biomarker and drug discovery assay markets. Furthermore, Enzo provides all the materials needed (dye- or biotin-labeled nucleotides, nick translation kits, hybridization solutions and developmental chemistry) to generate the highest quality fluorescence and chromogenic in situ hybridization experiments. Their products span a number of application areas including neuroscience, cancer, immunology, epigenetics, metabolism, and more. They publish bi-weekly TechNotes with tips, new research, and more, staying true to their motto “scientists enabling scientists.
苏州蚂蚁淘生物科技有限公司成立于2017年，致力于将全球领先的创新产品和前沿技术带入中国，帮助国内科研工作者在第一时间接触世界范围内的技术革命，并分享研发工具的进步带来的技术红利。依托于集团公司深厚的资源和超过400家的国内优质客户群体，生命科学领域的一站式供应链体系，以及高风险生物危险材料进出口平台的优势，蚂蚁淘生物严格筛选国际创新且经过同行验证过的产品和技术，引入中国市场，开发、孵育和推广。公司的未来将立足于实验室大数据整合和电子商务，结合严格的品牌筛选、创新的营销模式、专注的应用支持和坚实服务，帮助实现生命科学产业链的简单和高效。
瑞士Enzo Life Sciences www.enzolifesciences.com www.enzo.com Enzo Biochem Inc：（NYSE:ENZ） 这是一家致力于主要遗传学过程的研究工具，诊断，治疗和相关医学团体实验室服务的领先生命科学与生物技术公司。成立于1976年，集中于基因调控和基因修饰等方面的工具方法发展。 代理 Enzo Biochem, Inc. (Enzo) is engaged in research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally. The Company also operates a clinical laboratory that offers and provides diagnostic medical testing services to the health care community in the New York Metropolitan and New Jersey areas. The Company operates in three segments: Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical Labs. On May 8, 2008, Enzo Life Sciences, Inc., a wholly owned subsidiary of the Company, acquired all of the United States-based assets of Biomol International, LP (Biomol) and its wholly owned United Kingdom subsidiary, Affinity Limited. ENZO® - A Brand of Enzo Life Sciences, Inc. Innovative Labeling and Detection™ Enzo® is a recognized leader in labeling and detection technologies across research and diagnostic markets. A strong portfolio of labeling probes and dyes provides life science environments tools for target identification/validation and high content analysis via gene expression analysis, nucleic acid detection, protein biochemistry and detection, and molecular and cellular biology.
